Liou JP - Search Results

1

Anticancer activity of MPT0E028, a novel potent histone deacetylase inhibitor, in human colorectal cancer HCT116 cells in vitro and in vivo.

Huang HL, Lee HY, Tsai AC, Peng CY, Lai MJ, Wang JC, Pan SL, Teng CM, Liou JP. Huang HL, et al. Among authors: liou jp. PLoS One. 2012;7(8):e43645. doi: 10.1371/journal.pone.0043645. Epub 2012 Aug 22. PLoS One. 2012. PMID: 22928010 Free PMC article.

2

BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.

Kuo CC, Hsieh HP, Pan WY, Chen CP, Liou JP, Lee SJ, Chang YL, Chen LT, Chen CT, Chang JY. Kuo CC, et al. Among authors: liou jp. Cancer Res. 2004 Jul 1;64(13):4621-8. doi: 10.1158/0008-5472.CAN-03-3474. Cancer Res. 2004. PMID: 15231674

3

Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.

Liou JP, Chang YL, Kuo FM, Chang CW, Tseng HY, Wang CC, Yang YN, Chang JY, Lee SJ, Hsieh HP. Liou JP, et al. J Med Chem. 2004 Aug 12;47(17):4247-57. doi: 10.1021/jm049802l. J Med Chem. 2004. PMID: 15293996

4

Combretastatin A4-induced differential cytotoxicity and reduced metastatic ability by inhibition of AKT function in human gastric cancer cells.

Lin HL, Chiou SH, Wu CW, Lin WB, Chen LH, Yang YP, Tsai ML, Uen YH, Liou JP, Chi CW. Lin HL, et al. Among authors: liou jp. J Pharmacol Exp Ther. 2007 Oct;323(1):365-73. doi: 10.1124/jpet.107.124966. Epub 2007 Jul 23. J Pharmacol Exp Ther. 2007. PMID: 17646428

5

A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.

Liou JP, Hsu KS, Kuo CC, Chang CY, Chang JY. Liou JP, et al. J Pharmacol Exp Ther. 2007 Oct;323(1):398-405. doi: 10.1124/jpet.107.126680. Epub 2007 Jul 27. J Pharmacol Exp Ther. 2007. PMID: 17660383

6

4- and 5-aroylindoles as novel classes of potent antitubulin agents.

Liou JP, Wu CY, Hsieh HP, Chang CY, Chen CM, Kuo CC, Chang JY. Liou JP, et al. J Med Chem. 2007 Sep 6;50(18):4548-52. doi: 10.1021/jm070557q. Epub 2007 Aug 8. J Med Chem. 2007. PMID: 17685504

7

Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents.

Reddy GR, Kuo CC, Tan UK, Coumar MS, Chang CY, Chiang YK, Lai MJ, Yeh JY, Wu SY, Chang JY, Liou JP, Hsieh HP. Reddy GR, et al. Among authors: liou jp. J Med Chem. 2008 Dec 25;51(24):8163-7. doi: 10.1021/jm8008635. J Med Chem. 2008. PMID: 19053773

8

Synthesis and structure-activity relationships of 1-benzyl-4,5,6-trimethoxyindoles as a novel class of potent antimitotic agents.

Lai MJ, Kuo CC, Yeh TK, Hsieh HP, Chen LT, Pan WY, Hsu KY, Chang JY, Liou JP. Lai MJ, et al. Among authors: liou jp. ChemMedChem. 2009 Apr;4(4):588-93. doi: 10.1002/cmdc.200800405. ChemMedChem. 2009. PMID: 19266513

9

2-amino-3,4,5-trimethoxybenzophenones as potent tubulin polymerization inhibitors.

Chuang HY, Chang JY, Lai MJ, Kuo CC, Lee HY, Hsieh HP, Chen YJ, Chen LT, Pan WY, Liou JP. Chuang HY, et al. Among authors: liou jp. ChemMedChem. 2011 Mar 7;6(3):450-6. doi: 10.1002/cmdc.201000479. Epub 2011 Jan 4. ChemMedChem. 2011. PMID: 21360819

10

Synthesis and biological evaluation of 4-aroyl-6,7,8-trimethoxyquinolines as a novel class of anticancer agents.

Hsieh CC, Lee HY, Nien CY, Kuo CC, Chang CY, Chang JY, Liou JP. Hsieh CC, et al. Among authors: liou jp. Molecules. 2011 Mar 7;16(3):2274-84. doi: 10.3390/molecules16032274. Molecules. 2011. PMID: 21383664 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters